EP3429693
NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF
:
EP einkaleyfi: Þýðing ekki lögð inn:
13.3.2017:
23.8.2023:
17713127.3
:
12.3.2037
:
NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF
13.3.2017
23.8.2023
:
Mersana Therapeutics, Inc.:
840 Memorial Drive, Cambridge, MA 02139, US
:
BERGSTROM, Donald, A.:
Winchester MA 01890, US
:
BODYAK, Natalya, D.:
Boston MA 02135, US
:
LOWINGER, Timothy, B.:
Carlisle MA 01741, US
:
PARK, Peter, U.:
Lincoln MA 01773, US
:
POLING, Laura, L.:
Acton MA 01720, US
:
YURKOVETSKIY, Aleksandr, V.:
Littleton MA 01460, US
:
201662308567 P:
15.3.2016:
US
:
201662323068 P:
15.4.2016:
US
:
201662383324 P:
2.9.2016:
US
:
US2017022155:
13.3.2017
:
A61K 47/68, A61P 35/00, A61K 47/59